<qa>  How many subjects will participate in the study?HTM will develop the TELLYHealth tm system that will provide education on hearing aid use and maintenance. HTM will conduct a randomized controlled trial RCT to quantify the benefits of TELLYHealth to patients and audiologists including: reductions in hearing handicap, improved knowledge of hearing aid handling, use and communications strategies; and improved audiologist aftercare. The investigators will recruit 80 subjects half in each group and each subject will participate in the study for 12 weeks. 